QR codes have been around for a while. Yet, their influence continues to grow. While it is believed that their time has come to an end, the situation in the pharmaceutical industry proves otherwise. When you take into account their help in tracking products, gathering information, and safety above all, you can see how they … Read more
Anxiety is a natural response to stress, characterized by feelings of fear or apprehension. It becomes a concern when these feelings are disproportionate and persistent, affecting daily functioning. Understanding this condition is pivotal in exploring the role of medications in its management. The Nature of Anxiety Anxiety is a multifaceted condition, manifesting in various forms … Read more
Steve G. Peters, M.D. is Professor of Medicine in the Division of Pulmonary and Critical Care at the Mayo Clinic in Rochester, MN. Disclosure: Dr. Peters is on the NAMDRC Board of Directors and serves as Advisor to the CPT Panel of the AMA, representing the American College of Chest Physicians. Current Procedural Terminology (CPT®) … Read more
Chronic Obstructive Pulmonary Disease (COPD) represents an umbrella term that includes chronic bronchitis, emphysema, and refractory asthma. It is a progressive disease, meaning it worsens over time, typically leading to increasingly severe symptoms and respiratory complications. It’s crucial to understand COPD, not only because it is the third leading cause of death globally but also … Read more
Do you wake up with a parched mouth, a rough, scratchy throat, or a feeling that you’ve just swallowed a handful of sand while using your Continuous Positive Airway Pressure (CPAP) machine? You’re not alone. Many individuals who use CPAP therapy for sleep apnea report dry mouth as a common side effect. A dry mouth … Read more
On December 20, 2017 the FDA removed its most prominent warning, the Boxed Warning, about asthma-related death from the drug labels of medicines that contain both an ICS and LABA. These include Advair Diskus, Advair HFA, Airduo Respiclick, Breo Ellipta, Dulera, and Symbicort. The controversy surrounding LABAs has persisted since salmeterol was originally approved by the FDA … Read more